Septerna, Inc. Common Stock
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 … Read more
Septerna, Inc. Common Stock (SEPN) - Total Assets
Latest total assets as of September 2025: $606.65 Million USD
Based on the latest financial reports, Septerna, Inc. Common Stock (SEPN) holds total assets worth $606.65 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Septerna, Inc. Common Stock - Total Assets Trend (2022–2024)
This chart illustrates how Septerna, Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Septerna, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
Septerna, Inc. Common Stock's total assets of $606.65 Million consist of 78.2% current assets and 21.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 52.2% |
| Accounts Receivable | $1.12 Million | 0.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2024)
This chart illustrates how Septerna, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Septerna, Inc. Common Stock's current assets represent 78.2% of total assets in 2024, a decrease from 88.3% in 2022.
- Cash Position: Cash and equivalents constituted 52.2% of total assets in 2024, down from 84.7% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 0.3% of total assets.
Septerna, Inc. Common Stock Competitors by Total Assets
Key competitors of Septerna, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Septerna, Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Septerna, Inc. Common Stock generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Septerna, Inc. Common Stock is currently not profitable relative to its asset base.
Septerna, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.53 | 10.08 | 16.30 |
| Quick Ratio | 6.53 | 10.08 | 16.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $416.40 Million | $ 120.18 Million | $ 105.76 Million |
Septerna, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Septerna, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.17 |
| Latest Market Cap to Assets Ratio | 1.03 |
| Asset Growth Rate (YoY) | 248.9% |
| Total Assets | $456.55 Million |
| Market Capitalization | $471.92 Million USD |
Valuation Analysis
Above Book Valuation: The market values Septerna, Inc. Common Stock's assets above their book value (1.03 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Septerna, Inc. Common Stock's assets grew by 248.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Septerna, Inc. Common Stock (2022–2024)
The table below shows the annual total assets of Septerna, Inc. Common Stock from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $456.55 Million | +248.87% |
| 2023-12-31 | $130.87 Million | +262.32% |
| 2022-12-31 | $36.12 Million | -- |